Abstract
Many flaviviruses, including yellow fever virus, dengue virus, Japanese encephalitis virus, tick-borne encephalitis virus, and West Nile virus, are globally important human pathogens. Despite an emergence and resurgence of flavivirus-mediated disease, specific therapies are not yet available; however, significant progress has been made toward the prevention and treatment of flavivirus infections. In this article we review recent advances made in the areas of (i) flavivirus vaccine development, and (ii) antiflavivirus drug discovery reported in literature and patents, and highlight strategies used in these investigations.
Keywords: Flavivirus, vaccine, antiviral, drug discovery, RNA virus, inhibitor
Recent Patents on Anti-Infective Drug Discovery
Title: Recent Advances in Flavivirus Antiviral Drug Discovery and Vaccine Development
Volume: 1 Issue: 1
Author(s): Debashish Ray and Pei-Yong Shi
Affiliation:
Keywords: Flavivirus, vaccine, antiviral, drug discovery, RNA virus, inhibitor
Abstract: Many flaviviruses, including yellow fever virus, dengue virus, Japanese encephalitis virus, tick-borne encephalitis virus, and West Nile virus, are globally important human pathogens. Despite an emergence and resurgence of flavivirus-mediated disease, specific therapies are not yet available; however, significant progress has been made toward the prevention and treatment of flavivirus infections. In this article we review recent advances made in the areas of (i) flavivirus vaccine development, and (ii) antiflavivirus drug discovery reported in literature and patents, and highlight strategies used in these investigations.
Export Options
About this article
Cite this article as:
Ray Debashish and Shi Pei-Yong, Recent Advances in Flavivirus Antiviral Drug Discovery and Vaccine Development, Recent Patents on Anti-Infective Drug Discovery 2006; 1 (1) . https://dx.doi.org/10.2174/157489106775244055
DOI https://dx.doi.org/10.2174/157489106775244055 |
Print ISSN 1574-891X |
Publisher Name Bentham Science Publisher |
Online ISSN 2212-4071 |
Related Articles
-
Inflammatory Process as a Determinant Factor for the Degeneration of Substantia Nigra Dopaminergic Neurons: Possible Relevance to the Etiology of Parkinsons Disease
Current Medicinal Chemistry - Central Nervous System Agents Agaricus blazei Water Extracts as Alternative Medicines
Current Pharmaceutical Analysis From Surface to Nuclear Receptors: The Endocannabinoid Family Extends its Assets
Current Medicinal Chemistry Evaluating a Child with Partial Developmental Delay (ParDD), Global Developmental Delay (GDD)/Mental Retardation (MR): Clinical Expertise Based or Evidence-Based?
Current Pediatric Reviews Development of Global Consensus of Dengue Virus Envelope Glycoprotein for Epitopes Based Vaccine Design
Current Computer-Aided Drug Design Neuroprotection by Estrogen and Progesterone in Traumatic Brain Injury and Spinal Cord Injury
Current Neuropharmacology HIV-1 Capsid Inhibitors as Antiretroviral Agents
Current HIV Research Toll-Like Receptors and Human Disease: Lessons from Single Nucleotide Polymorphisms
Current Genomics Polyphenols Beyond Barriers: A Glimpse into the Brain
Current Neuropharmacology CCR2 Antagonists
Current Topics in Medicinal Chemistry Autoantibodies in Autoimmune Diseases
Current Pharmaceutical Design Mentha L. Species (Lamiaceae) as Promising Sources of Bioactive Secondary Metabolites
Current Pharmaceutical Design Targeting Pattern Recognition Receptors (PRRs) in Nano- Adjuvants: Current Perspectives
Current Bionanotechnology (Discontinued) Endothelial Chemokines in Autoimmune Disease
Current Pharmaceutical Design Attenuated D2 16681-PDK53 Vaccine: Defining Humoral and Cell- Mediated Immunity
Current Pharmaceutical Design Infection, Infectious Agents and Vascular Disease
Reviews on Recent Clinical Trials CNS Drug Delivery Systems: Novel Approaches
Recent Patents on Drug Delivery & Formulation Sulfonamides: Antiviral Strategy for Neglected Tropical Disease Virus
Current Organic Chemistry Recent Development and Future Prospects of Plant-Based Vaccines
Current Drug Metabolism Microbiota Regulation of Inflammatory Bowel Disease
Inflammation & Allergy - Drug Targets (Discontinued)